- Home
- PTCT vs SON Comparison
PTCT vs SON Comparison
Compare PTCT & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- SON
- Stock Information
- Founded
- PTCT 1998
- SON 1899
- Country
- PTCT United States
- SON United States
- Employees
- PTCT N/A
- SON N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- SON Containers/Packaging
- Sector
- PTCT Health Care
- SON Consumer Discretionary
- Exchange
- PTCT Nasdaq
- SON Nasdaq
- Market Cap
- PTCT 3.9B
- SON 4.3B
- IPO Year
- PTCT 2013
- SON N/A
- Fundamental
- Price
- PTCT $50.73
- SON $46.22
- Analyst Decision
- PTCT Buy
- SON Strong Buy
- Analyst Count
- PTCT 14
- SON 8
- Target Price
- PTCT $67.64
- SON $57.63
- AVG Volume (30 Days)
- PTCT 1.0M
- SON 972.5K
- Earning Date
- PTCT 08-07-2025
- SON 07-23-2025
- Dividend Yield
- PTCT N/A
- SON 4.48%
- EPS Growth
- PTCT N/A
- SON 50.35
- EPS
- PTCT 7.51
- SON 5.60
- Revenue
- PTCT $1,772,758,000.00
- SON $6,337,597,000.00
- Revenue This Year
- PTCT $120.38
- SON $45.40
- Revenue Next Year
- PTCT N/A
- SON $0.70
- P/E Ratio
- PTCT $6.60
- SON $8.45
- Revenue Growth
- PTCT 91.12
- SON 28.33
- 52 Week Low
- PTCT $29.02
- SON $39.46
- 52 Week High
- PTCT $58.38
- SON $56.77
- Technical
- Relative Strength Index (RSI)
- PTCT 54.87
- SON 51.31
- Support Level
- PTCT $44.15
- SON $47.35
- Resistance Level
- PTCT $47.61
- SON $50.09
- Average True Range (ATR)
- PTCT 1.74
- SON 1.08
- MACD
- PTCT -0.12
- SON 0.02
- Stochastic Oscillator
- PTCT 81.20
- SON 30.96
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.